BRD4-IN-12, CAS [[3112325-99-9]]

Produktübersicht

• Artikelname: BRD4-IN-12, CAS [[3112325-99-9]]
• Artikelnummer: MCE-HY-181505
• Hersteller Artikelnummer: HY-181505
• Alternativnummer: MCE-HY-181505-5MG,MCE-HY-181505-10MG,MCE-HY-181505-25MG,MCE-HY-181505-50MG,MCE-HY-181505-100MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

BRD4-IN-12 is a potent and orally active BRD4 inhibitor with an IC50 of 7.9 nM. BRD4-IN-12 downregulates the expression of c-MYC, BCL-2, CDK4 and upregulates p21. BRD4-IN-12 inhibits tumor cell proliferation and promotes apoptosis. BRD4-IN-12 exhibits excellent antitumor effects in the HCT-116 colorectal cancer xenograft model. BRD4-IN-12 can be used for the study of colorectal cancer (CRC)[1].

Produkteigenschaften

• Molekulargewicht: 428.50
• CAS Nummer: [3112325-99-9]
• Formel: C21H24N4O4S
• Target-Kategorie: Apoptosis,Bcl-2 Family,c-Myc,Epigenetic Reader Domain,PAK

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound